Imugene Limited (ASX:IMU) Doses First Australian Patient in Phase 1b Trial
Imugene Limited (ASX:IMU) announces the first Australian patient has been dosed in its Phase 1b azer-cel trial for DLBCL.

Imugene Limited (ASX:IMU) announces the first Australian patient has been dosed in its Phase 1b azer-cel trial for DLBCL.
Katana Capital Limited (ASX:KAT) announces an on-market buy-back of up to 3,142,313 securities, starting January 2, 2025.
TMK Energy reports robust performance with pilot production wells at Gurvantes XXXV, indicating a strong operational outlook.
Minerals 260 Limited has announced a trading halt pending news of a material acquisition.
Jervois Global (ASX:JRV) has signed a recapitalisation agreement with Millstreet Capital to strengthen its balance sheet and boost operational efficiency.
Jervois Global (ASX:JRV) has requested a voluntary suspension to manage disclosure obligations related to its recapitalisation plans.
Cygnus Metals and Doré Copper announce the completion of their merger, creating a leading player in the critical minerals sector.
Renergen Limited (ASX:RLT) reported stable LNG and helium production while addressing liquidity and legal matters regarding the Springbok Solar project.
Triton Minerals (ASX:TON) updates on Share Sale Agreement with Shandong Yulong Group, confirming changes in payment structure.
88 Energy (ASX:88E) updates on Project Phoenix, highlighting joint venture progress and upcoming strategic initiatives.